“…Thus, a more in-depth understanding of the concept of the stem cell-paved biobridge in neurodegenerative diseases potentially amendable by this therapeutic action, including ischemic stroke, hypoxic-ischemic encephalopathy (HIE), and cerebral palsy (CP) among others, may yield important therapeutic benefits (Tajiri et al, 2014). These disorders are each characterized, in part, by sites of cellular degeneration, separated from neurogenic areas of the brain that could otherwise facilitate the recovery of severe damaged cells (Failor et al, 2010; Rinholm et al, 2011; Xiong et al, 2011; Tajiri et al, 2013; Merson and Bourne, 2014; Tajiri et al, 2014; Duncan et al, 2015; Ranasinghe et al, 2015; Heiss and Zaro-Weber, 2017). …”